by Clinical Neuropsychologist | Monday, September 16, 2024 | Dementia
Abstract This paper for the 20th anniversary of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) provides an overview of magnetic resonance imaging (MRI) of medial temporal lobe (MTL) subregions in ADNI using a dedicated high-resolution T2-weighted...
by Clinical Neuropsychologist | Saturday, September 14, 2024 | Dementia
Dementia, Volume 24, Issue 3, Page 424-435, April 2025. Background:Social service professionals routinely use screening tools to assess for cognitive decline or identify suspected dementia in nursing home residents. Published literature lacks details about the...
by Clinical Neuropsychologist | Thursday, September 12, 2024 | Dementia
Abstract INTRODUCTION Recent advances in biomarker research have improved the diagnosis and monitoring of Alzheimer’s disease (AD), but in vivo biomarker-based workflows to assess 4R-tauopathy (4RT) patients are currently missing. We suggest a novel...
by Clinical Neuropsychologist | Thursday, September 12, 2024 | Dementia
Abstract INTRODUCTION The molecular basis of cognitive resilience (CR) among pathologically confirmed Alzheimer’s disease (AD) cases is not well understood. METHODS Abundance of 13 cell types and neuronal subtypes in brain bulk RNA-seq data from the anterior...
by Clinical Neuropsychologist | Thursday, September 12, 2024 | Dementia
Abstract INTRODUCTION Regional glucose hypometabolism resulting in glutamate loss has been shown as one of the characteristics of Alzheimer’s disease (AD). Because the impact of AD varies between the sexes, we utilized glutamate-weighted chemical exchange...
